Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2013; 19(36): 6035-6043
Published online Sep 28, 2013. doi: 10.3748/wjg.v19.i36.6035
Published online Sep 28, 2013. doi: 10.3748/wjg.v19.i36.6035
RYGB (n = 609) | LAGB (n = 686) | |
Gender (M:F) | 116: 493 | 131: 555 |
Age (yr) | 42.4 ± 10.5b | 37.2 ± 9.4 |
Initial BMI (kg/m2) | 46.8 ± 7.1b | 40.4 ± 4.2 |
Co-morbidities (sub-group analysis) | (n = 301) | (n = 545) |
Total co-morbidities | 216 (71.0) | 363 (66.6) |
Type 2 diabetes mellitus (n) | 82 | 95 |
Hypertension (n) | 51 | 157 |
Hyperlipidemia (n) | 116 | 117 |
Obstructive sleep apnoea (n) | 97b | 113 |
Duration of follow-Median (yr) | 2.0 (1.0-5.0) | 1.6 (1.0-2.2) |
- Citation: Nguyen NQ, Game P, Bessell J, Debreceni TL, Neo M, Burgstad CM, Taylor P, Wittert GA. Outcomes of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding. World J Gastroenterol 2013; 19(36): 6035-6043
- URL: https://www.wjgnet.com/1007-9327/full/v19/i36/6035.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i36.6035